glp-1 coverage medicaid MCT2D The evolving landscape of anti-obesity

Mention or tag @bakedlean

Risk assessment should extend beyond medication use alone and incorporate evaluation of gastrointestinal symptoms, treatment stage, dosage escalation status, underlying motility disorders, diabetes-related complications, and the urgency of the planned procedure

This synergy not only supports weight loss efforts but also optimizes overall health, which is crucial for both surgical candidates and those pursuing non-surgical cosmetic treatments

1-Minute Form | FREE Consultation Start Your Weight Loss Journey with GLP-1 Today Unlock your potential with personalized weight loss plans built around your goals and lifestyle

Drugs like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) are now mainstream, with patients often asking about them before clinicians bring them up

From desert lizard venom to approved medication took roughly 20 years